Feb. 12, 2026
AnaptysBio Details Q2 Royalty Spin, Jemperli Growth and ANB033 Celiac Data Coming in Q4
Biopharma company outlines plans to separate royalty and clinical-stage businesses, highlights key pipeline updates and upcoming catalysts.
Feb. 11, 2026
Robbins LLP Reminds BellRing Brands Investors of Class Action Lawsuit
Law firm urges investors to reach out for information on the BRBR class action lawsuit.
Feb. 11, 2026
Neurocrine Biosciences Reports Strong 2025 Sales, Outlines 2026 Priorities
Company touts continued momentum for INGREZZA and successful launch of CRENESSITY, while advancing pipeline of next-gen therapies.
Feb. 10, 2026
Genasys Reports Fiscal Q1 Loss
Directed sound tech company posts $17.1 million in revenue
Feb. 10, 2026
Robbins LLP Files Class Action Against Inovio Pharmaceuticals
Lawsuit alleges Inovio misled investors about manufacturing issues with its CELLECTRA device.
